Incidence and prevalence of Toxoplasma gondii infection in women in France, 1980-2020: model-based estimation

被引:77
作者
Nogareda, F. [1 ,2 ]
Le Strat, Y. [1 ]
Villena, I. [3 ]
De Valk, H. [1 ]
Goulet, V. [1 ]
机构
[1] French Inst Publ Hlth Surveillance InVS, Dept Infect Dis, F-94415 St Maurice, France
[2] European Ctr Dis Prevent & Control ECDC, European Programme Intervent Epidemiol Training, Stockholm, Sweden
[3] CHU Hop Maison Blanche, Ctr Natl Reference Toxoplasmose, EA3800, Lab Parasitol Mycol, Reims, France
关键词
Incidence; modelling; prevalence; toxoplasmosis; PREGNANT-WOMEN; UNITED-STATES; VIRUS-INFECTIONS; RISK-FACTORS; SEROPREVALENCE; TRANSMISSION; POPULATION;
D O I
10.1017/S0950268813002756
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Toxoplasmosis is a worldwide zoonosis due to Toxoplasma gondii, a ubiquitous protozoan parasite of warm-blooded animals including humans. In pregnant women, primary infection can cause congenital toxoplasmosis resulting in severe malformations in the newborn. Since 1978, public health authorities in France have implemented a congenital toxoplasmosis prevention programme, including monthly serological screening of all seronegative pregnant women, and treatment in case of seroconversion. However, this programme does not produce systematic surveillance data on incidence and prevalence. Our objective was to estimate the incidence and prevalence of T. gondii infection, and the incidence of seroconversion during pregnancy in women in France. We used a catalytic model to estimate incidence and prevalence of Toxoplasma infection between 1980 and 2020 in women of childbearing age. We used age-and time-specific seroprevalence data obtained from the National Perinatal Surveys (NPS) conducted in 1995, 2003 and 2010. We assumed that incidence depends both on age and calendar time, and can be expressed as the product of two unknown functions. We also estimated incidence of seroconversion during pregnancy in 2010 from the NPS and the National Surveillance of Congenital Toxoplasmosis (ToxoSurv). We combined data of 42208 women aged 15-45 years with serology available from the three NPS. For women aged 30 years the modelled incidence decreased from 7.5/1000 susceptible women in 1980 to 3.5/1000 in 2000. In 2010 the incidence was 2.4/1000. The predicted incidence and prevalence for 2020 was 1.6/1000 and 27%, respectively. The incidence of seroconversion during pregnancy in 2010 was estimated at 2.1/1000 susceptible pregnant women (95% CI 1.3-3.1) from the NPS and 1.9 (95% CI 1.8-2.1) from ToxoSurv. Incidence and prevalence of Toxoplasma infection has decreased markedly during the last 30 years. This decrease may be explained by a lower exposure to the parasite by changes in food habits and by improved hygiene practices in meat production. Modelled estimations were consistent with estimates observed in other studies conducted previously in France. The catalytic modelling provides reliable estimates of incidence and prevalence of Toxoplasma infection over time. This approach might be useful for evaluating preventive programme for toxoplasmosis.
引用
收藏
页码:1661 / 1670
页数:10
相关论文
共 39 条
[31]   A community-based survey of Toxoplasma gondii infection among pregnant women in rural areas of Taiz governorate, Yemen: the risk of waterborne transmission [J].
Mohammed A. K. Mahdy ;
Lina M. Q. Alareqi ;
Rashad Abdul-Ghani ;
Samira M. A. Al-Eryani ;
Abdullah A. Al-Mikhlafy ;
Abdulsalam M. Al-Mekhlafi ;
Fawzya Alkarshy ;
Rohela Mahmud .
Infectious Diseases of Poverty, 6
[32]   Model-Based Estimation of Viral Transmissibility and Infection-Induced Resistance From the Age-Dependent Prevalence of Infection for 14 High-Risk Types of Human Papillomavirus [J].
Bogaards, Johannes A. ;
Xiridou, Maria ;
Coupe, Veerle M. H. ;
Meijer, Chris J. L. M. ;
Wallinga, Jacco ;
Berkhof, Johannes .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2010, 171 (07) :817-825
[33]   Model-based small area estimation methods and precise district-level HIV prevalence estimates in Uganda [J].
Ouma, Joseph ;
Jeffery, Caroline ;
Awor, Colletar Anna ;
Muruta, Allan ;
Musinguzi, Joshua ;
Wanyenze, Rhoda K. ;
Biraro, Sam ;
Levin, Jonathan ;
Valadez, Joseph J. .
PLOS ONE, 2021, 16 (08)
[34]   Multi-test analysis and model-based estimation of the prevalence of Taenia saginata cysticercus infection in naturally infected dairy cows in the absence of a 'gold standard' reference test [J].
Eichenberger, R. M. ;
Lewis, F. ;
Gabriel, S. ;
Dorny, P. ;
Torgerson, P. R. ;
Deplazes, P. .
INTERNATIONAL JOURNAL FOR PARASITOLOGY, 2013, 43 (10) :853-859
[35]   Changes in chlamydia prevalence and duration of infection estimated from testing and diagnosis rates in England: a model-based analysis using surveillance data, 2000-15 [J].
Lewis, Joanna ;
White, Peter J. .
LANCET PUBLIC HEALTH, 2018, 3 (06) :E271-E278
[36]   HIV epidemic drivers in South Africa: A model-based evaluation of factors accounting for inter-provincial differences in HIV prevalence and incidence trends [J].
Johnson, Leigh F. ;
Dorrington, Rob E. ;
Moolla, Haroon .
SOUTHERN AFRICAN JOURNAL OF HIV MEDICINE, 2017, 18 (01)
[37]   Median Age at HPV Infection Among Women in the United States: A Model-Based Analysis Informed by Real-world Data [J].
Prabhu, Vimalanand S. ;
Roberts, Craig S. ;
Kothari, Smita ;
Niccolai, Linda .
OPEN FORUM INFECTIOUS DISEASES, 2021, 8 (07) :1-8
[38]   Trends in Incidence Rates during 1999-2008 and Prevalence in 2008 of Childhood Type 1 Diabetes Mellitus in GERMANY - Model-Based National Estimates [J].
Bendas, Alexander ;
Rothe, Ulrike ;
Kiess, Wieland ;
Kapellen, Thomas Michael ;
Stange, Thoralf ;
Manuwald, Ulf ;
Salzsieder, Eckhard ;
Holl, Reinhard Walter ;
Schoffer, Olaf ;
Stahl-Pehe, Anna ;
Giani, Guido ;
Ehehalt, Stefan ;
Neu, Andreas ;
Rosenbauer, Joachim .
PLOS ONE, 2015, 10 (07)
[39]   The impact of new direct-acting antiviral therapy on the prevalence and undiagnosed proportion of chronic hepatitis C infection in Alberta: A model-based analysis [J].
Forouzannia, Farinaz ;
Lewis, Diedron ;
Eze, Nkiruka ;
Clement, Fiona ;
Wong, William W. L. .
CANADIAN LIVER JOURNAL, 2025, 0 (AOP)